HEALTH CATALYST INC (HCAT) Institutional Ownership

HCAT is currently held by 1 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $275,678 based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026.

The largest disclosed holder is Renaissance Technologies LLC, which reported ownership valued at approximately $275,678 in its March 31, 2026 13F filing. Based on current market prices and the latest disclosed share count, Renaissance Technologies LLC's HCAT position is now estimated to be worth approximately $384,212.13, representing an estimated gain of +39.37% since the filing period.

Major shareholders tracked on this page include Renaissance Technologies LLC, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks fund ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward HEALTH CATALYST INC (HCAT).

Institutional Ownership Trend

Portfolio quarterInstitutional holdersTotal reported valueTotal shares
Q1 20261$275,678217,069
Q3 20251$130,72745,869
Q2 20241$93,93314,700
Q1 20242$3,389,004516,900
Q4 20232$4,167,919549,269
Q3 20232$7,085,614859,469
Q2 20233$10,778,4711,016,723
Q1 20233$6,523,613825,809
Q4 20223$6,700,390818,502
Q3 20223$8,628889,513
Q2 20222$4,503310,800
Q1 20222$15,154579,916
HCAT Institutional Ownership and 13F Activity Q1 2026 | InsiderSet